candidate

Serina Therapeutics Secures $10 Million Financing to Continue Advancing Lead IND Candidate into Phase 1 Clinical Trial in Advanced Parkinson’s Disease Patients

HUNTSVILLE, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company, today announced…

3 weeks ago

IOC Ethics Commission draws lots to determine order of presidential candidate presentations

26 November 2024 - The International Olympic Committee (IOC) Ethics Commission arranged a drawing of lots to determine the order in which…

3 weeks ago

IOC Ethics Commission draws lots to determine order of presidential candidate presentations

26 November 2024 - The International Olympic Committee (IOC) Ethics Commission arranged a drawing of lots to determine the order in which…

3 weeks ago

IOC Ethics Commission draws lots to determine order of presidential candidate presentations

26 November 2024 - The International Olympic Committee (IOC) Ethics Commission arranged a drawing of lots to determine the order in which…

3 weeks ago

IOC Ethics Commission draws lots to determine order of presidential candidate presentations

26 November 2024 - The International Olympic Committee (IOC) Ethics Commission arranged a drawing of lots to determine the order in which…

4 weeks ago

IOC Ethics Commission draws lots to determine order of presidential candidate presentations

26 November 2024 - The International Olympic Committee (IOC) Ethics Commission arranged a drawing of lots to determine the order in which…

4 weeks ago

Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimers Disease

November 20, 2024 07:00 ET | Source: Voyager Therapeutics, Inc. - Candidate VY1706 demonstrates significant reductions of tau at low…

1 month ago

Fate Therapeutics Highlights Cancer-selective, HER2-Targeting Profile of FT825 / ONO-8250 CAR T-cell Product Candidate for Treatment of Advanced Solid Tumors at 2024 SITC Annual Meeting

Novel H2CasMab-2 Antigen Binding Domain Shown to Preferentially Target HER2 Expressed on Tumor Cells in Preclinical Studies Initial Low-Dose Cohort…

1 month ago